Skip to content Skip to footer
Professor

Timothy Mercer

Email: 
Phone: 
+61 7 334 64300

Overview

Background

Professor Tim Mercer is Founding Director of the BASE mRNA Facility at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, and an NHMRC Leadership Fellow.

BASE is a national NCRIS-supported facility that designs, manufactures and tests mRNA-LNP medicines. Its production facility at the Translational Research Institute supplies mRNA-LNPs to around 120 research laboratories across Australia, and its new clinical manufacturing suites will enable clinical-grade mRNA production. Tim's team develops new methods for mRNA design, manufacture and quality control, including the mRNArchitect design software, a single-step isothermal mRNA synthesis reaction, and nanopore sequencing for mRNA quality control.

Tim trained in computational biology and genomics, and his early work contributed to the discovery of long non-coding RNAs. He has held positions at the Broad Institute, the Max Planck Institute in Dresden, the Centre for Genomic Regulation in Barcelona and the Garvan Institute. He has translated his research into clinical tools, including targeted RNA sequencing, now a first-line diagnostic for cancer fusion genes, and synthetic RNA and DNA controls for clinical genome sequencing.

Tim serves on the Executive Board of the Alliance for mRNA Medicines and chairs its Asia-Pacific Committee.

Availability

Professor Timothy Mercer is:
Available for supervision

Qualifications

  • Doctor of Philosophy, The University of Queensland

Research interests

  • mRNA design and manufacture

    Developing new methods to design and manufacture mRNA medicines. This includes mRNArchitect, software for designing optimised mRNA sequences, and a single-step isothermal reaction that simplifies mRNA synthesis. We apply these tools to build mRNA vaccines and therapies with Australian research and clinical partners.

  • mRNA quality control and reference standards

    Using nanopore sequencing to measure mRNA sequence, integrity, 5' capping and poly(A) tails during manufacture. We develop reference standards with partners including NIST to support consistent quality control and regulation of mRNA medicines.

  • Targeted mRNA-LNP delivery

    Developing lipid nanoparticles that deliver mRNA to specific cell types, including immune cells for in vivo cell therapies.

  • RNA genomics and long-read sequencing

    Studying how the human genome is transcribed using long-read and targeted RNA sequencing. Earlier work contributed to the discovery of long non-coding RNAs and developed targeted RNA sequencing, now a clinical diagnostic for cancer fusion genes.

Research impacts

Tim's research has been translated into clinical diagnostics, industry standards and national manufacturing capability.

  • Cancer diagnostics. Tim developed targeted RNA sequencing, which was commercialised with Roche and is now a first-line diagnostic for cancer fusion genes. He raised philanthropic funding to establish the first targeted RNA sequencing fusion-gene test for Australian cancer patients at St Vincent's Hospital, Sydney.
  • Genome sequencing standards. Tim developed synthetic RNA and DNA controls for clinical genome sequencing, worked with the US FDA on regulatory recommendations for sequencing-based tests, and co-founded Sequins Pty Ltd to commercialise these standards.
  • Sovereign mRNA capability. As Founding Director of BASE, Tim established a national facility that supplies mRNA-LNPs to around 120 research laboratories across Australia, helping researchers develop new mRNA vaccines and therapies.
  • mRNA quality control. His team's nanopore sequencing methods for mRNA quality control are used by mRNA manufacturers and are informing international reference standards developed with NIST.

Works

Search Professor Timothy Mercer’s works on UQ eSpace

105 works between 2007 and 2026

1 - 20 of 105 works

2026

Journal Article

Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfection

Chavalparit, Thornwit, Barry, Craig, Gunter, Helen, Gillard, Marianne, Mercer, Timothy and Marcellin, Esteban (2026). Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfection. mAbs, 18 (1) 2599584, 1-17. doi: 10.1080/19420862.2025.2599584

Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfection

2026

Journal Article

Systemically delivered mRNA-LNPs transfect primary and secondary liver tumors

Leighton, Laura J., Gee, Yee Jing, Madugalle, Sachithrani U., Victorova, Maria, Carrodus, Nissa L., Bridle, Kim R., Howell, Sidney A., Liang, Xiaowen, Miller, Gregory C., McMillan, Chris L.D., Wijesundara, Danushka K., Muller, David A., Crawford, Darrell H.G., Mercer, Timothy R. and Cheetham, Seth W. (2026). Systemically delivered mRNA-LNPs transfect primary and secondary liver tumors. Molecular Therapy Nucleic Acids, 37 (3) 102989, 102989-3. doi: 10.1016/j.omtn.2026.102989

Systemically delivered mRNA-LNPs transfect primary and secondary liver tumors

2026

Journal Article

A playbook for harmonization of standards for emergent viral pathogens

Suliman, Sara, Fuchs, Sebastien, Catoe, David, Hansen, Loren, Eveleigh, Deepa, Crone, Michael A., Freemont, Paul S., Kammel, Martin, Zeichhardt, Heinz, Anfora, Andrew T., Garlick, Russell, Almond, Neil, Page, Mark, Beck, Brian, Wang, Hui, Sharma, Karuna, Pestano, Gary, Vancann, Joannes, Vandesompele, Jo, Corner, Adam S., Albrecht, Jeffrey, Boles, Deborah J., Eisenberg, Marcia, Harris, Ayla B., Krueger, Brian J., Suchanek, Amanda L., Urban, Thomas J., Williams, Jonathan D., Chain, Patrick ... Salit, Marc (2026). A playbook for harmonization of standards for emergent viral pathogens. Accreditation and Quality Assurance, 1-7. doi: 10.1007/s00769-026-01721-w

A playbook for harmonization of standards for emergent viral pathogens

2026

Conference Publication

Chemically and enzymatically synthesised messenger RNA as a therapeutic agent

Victorova, M., Yunis, J., O'Brien, L., Nielsen, D., Tompkins, H., Leighton, L., Mercer, T. and Cheetham, S. (2026). Chemically and enzymatically synthesised messenger RNA as a therapeutic agent. 32nd ISCT Scientific Annual Meeting, Dublin, Ireland, 6-9 May 2026. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jcyt.2026.102739

Chemically and enzymatically synthesised messenger RNA as a therapeutic agent

2026

Journal Article

Resolving single-cell gene expression by pseudo-temporal integration of transcriptomic and proteomic datasets

Barry, Craig P., Talbo, Gert H., Beauglehole, Aiden, Ovchinnikov, Dmitry, Munro, Trent, Mahler, Stephen, Baker, Kym, Nielsen, Lars K., Mercer, Tim R. and Marcellin, Esteban (2026). Resolving single-cell gene expression by pseudo-temporal integration of transcriptomic and proteomic datasets. Molecular and Cellular Proteomics, 25 (1) 101475, 1-14. doi: 10.1016/j.mcpro.2025.101475

Resolving single-cell gene expression by pseudo-temporal integration of transcriptomic and proteomic datasets

2025

Journal Article

Mind the cap: Detecting degradation impurities in synthetic mRNAs

Nielsen, Daniel, Victorova, Maria, Mercer, Timothy R. and Cheetham, Seth W. (2025). Mind the cap: Detecting degradation impurities in synthetic mRNAs. Molecular Therapy Nucleic Acids, 36 (4) 102701, 102701-4. doi: 10.1016/j.omtn.2025.102701

Mind the cap: Detecting degradation impurities in synthetic mRNAs

2025

Journal Article

Blood collection tube and RNA purification method recommendations for extracellular RNA transcriptome profiling

Yigit, Nurten, Verwilt, Jasper, Verniers, Kimberly, Van Paemel, Ruben, Van Maerken, Tom, Vandesompele, Jo, Vanden Eynde, Eveline, Thas, Olivier, Schroth, Gary P., Schoofs, Kathleen, Poma-Soto, Franco, Piofczyk, Thomas, Philippron, Annouck, Nuytens, Justine, Nijs, Nele, Morlion, Annelien, Mestdagh, Pieter, Mercer, Tim R., Kuersten, Scott, Koster, Jan, Hulstaert, Eva, Hendrix, An, Helsmoortel, Hetty H., Fierro, Carolina, Everaert, Celine, D’huyvetter, Thibaut, Dhondt, Bert, De Wilde, Jilke, De Wever, Olivier ... Anckaert, Jasper (2025). Blood collection tube and RNA purification method recommendations for extracellular RNA transcriptome profiling. Nature Communications, 16 (1) 4513, 1-17. doi: 10.1038/s41467-025-58607-7

Blood collection tube and RNA purification method recommendations for extracellular RNA transcriptome profiling

2025

Journal Article

The design, manufacture and LNP formulation of mRNA for research use

Leighton, Laura J., Chaudhary, Natasha, Tompkins, Hannah T., Kulkarni, Abhishek, Carrodus, Nissa L., Budzinska, Magdalena A., Lakshman Das, Sneha, Cheetham, Seth W. and Mercer, Tim R. (2025). The design, manufacture and LNP formulation of mRNA for research use. Nature Protocols, 20 (12), 3552-3581. doi: 10.1038/s41596-025-01174-4

The design, manufacture and LNP formulation of mRNA for research use

2025

Journal Article

Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell-surface markers

Dietmair, Bettina, Humphries, James, Mercer, Timothy R., Thurecht, Kristofer J., Howard, Christopher B. and Cheetham, Seth W. (2025). Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell-surface markers. Molecular Therapy Nucleic Acids, 36 (2) 102520, 1-7. doi: 10.1016/j.omtn.2025.102520

Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell-surface markers

2025

Journal Article

Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR

Lam, Pui Yeng, Omer, Natacha, Wong, Josh K. M., Tu, Cui, Alim, Louisa, Rossi, Gustavo R., Victorova, Maria, Tompkins, Hannah, Lin, Cheng-Yu, Mehdi, Ahmed M., Choo, Amos, Elliott, Melissa R., Coleborn, Elaina, Sun, Jane, Mercer, Timothy, Vittorio, Orazio, Dobson, Lachlan J., Mclellan, Alexander D., Brooks, Andrew, Tuong, Zewen Kelvin, Cheetham, Seth W., Nicholls, Wayne and Souza-Fonseca-Guimaraes, Fernando (2025). Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR. Clinical and Translational Medicine, 15 (1) e70140, 1-21. doi: 10.1002/ctm2.70140

Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR

2024

Journal Article

Targeted DNA-seq and RNA-seq of reference samples with short-read and long-read sequencing

Gong, Binsheng, Li, Dan, Labaj, Pawel P., Pan, Bohu, Novoradovskaya, Natalia, Thierry-Mieg, Danielle, Thierry-Mieg, Jean, Chen, Guangchun, Bergstrom Lucas, Anne, Lococo, Jennifer S., Richmond, Todd A., Tseng, Elizabeth, Kusko, Rebecca, Happe, Scott, Mercer, Timothy R., Pabon-Pena, Carlos, Salmans, Michael, Tilgner, Hagen U., Xiao, Wenzhong, Johann, Donald J., Jones, Wendell, Tong, Weida, Mason, Christopher E., Kreil, David P. and Xu, Joshua (2024). Targeted DNA-seq and RNA-seq of reference samples with short-read and long-read sequencing. Scientific Data, 11 (1) 892, 892. doi: 10.1038/s41597-024-03741-y

Targeted DNA-seq and RNA-seq of reference samples with short-read and long-read sequencing

2024

Journal Article

Ageing-related changes to H3K4me3, H3K27ac, and H3K27me3 in purified mouse neurons

Signal, Brandon, Phipps, Andrew J., Giles, Katherine A., Huskins, Shannon N., Mercer, Timothy R., Robinson, Mark D., Woodhouse, Adele and Taberlay, Phillippa C. (2024). Ageing-related changes to H3K4me3, H3K27ac, and H3K27me3 in purified mouse neurons. Cells, 13 (16) 1393, 1-21. doi: 10.3390/cells13161393

Ageing-related changes to H3K4me3, H3K27ac, and H3K27me3 in purified mouse neurons

2024

Journal Article

A universal molecular control for DNA, mRNA and protein expression

Gunter, Helen M., Youlten, Scott E., Reis, Andre L. M., McCubbin, Tim, Madala, Bindu Swapna, Wong, Ted, Stevanovski, Igor, Cipponi, Arcadi, Deveson, Ira W., Santini, Nadia S., Kummerfeld, Sarah, Croucher, Peter I., Marcellin, Esteban and Mercer, Tim R. (2024). A universal molecular control for DNA, mRNA and protein expression. Nature Communications, 15 (1) 2480, 1-13. doi: 10.1038/s41467-024-46456-9

A universal molecular control for DNA, mRNA and protein expression

2023

Journal Article

Parallel laboratory evolution and rational debugging reveal genomic plasticity to S. cerevisiae synthetic chromosome XIV defects

Williams, Thomas C., Kroukamp, Heinrich, Xu, Xin, Wightman, Elizabeth L. I., Llorente, Briardo, Borneman, Anthony R., Carpenter, Alexander C., Van Wyk, Niel, Meier, Felix, Collier, Thomas R. V., Espinosa, Monica I., Daniel, Elizabeth L., Walker, Roy S. K., Cai, Yizhi, Nevalainen, Helena K. M., Curach, Natalie C., Deveson, Ira W., Mercer, Timothy R., Johnson, Daniel L., Mitchell, Leslie A., Bader, Joel S., Stracquadanio, Giovanni, Boeke, Jef D., Goold, Hugh D., Pretorius, Isak S. and Paulsen, Ian T. (2023). Parallel laboratory evolution and rational debugging reveal genomic plasticity to S. cerevisiae synthetic chromosome XIV defects. Cell Genomics, 3 (11) 100379, 1-23. doi: 10.1016/j.xgen.2023.100379

Parallel laboratory evolution and rational debugging reveal genomic plasticity to S. cerevisiae synthetic chromosome XIV defects

2023

Journal Article

mRNA vaccine quality analysis using RNA sequencing

Gunter, Helen M., Idrisoglu, Senel, Singh, Swati, Han, Dae Jong, Ariens, Emily, Peters, Jonathan R., Wong, Ted, Cheetham, Seth W., Xu, Jun, Rai, Subash Kumar, Feldman, Robert, Herbert, Andy, Marcellin, Esteban, Tropee, Romain, Munro, Trent and Mercer, Tim R. (2023). mRNA vaccine quality analysis using RNA sequencing. Nature Communications, 14 (1) 5663, 1-12. doi: 10.1038/s41467-023-41354-y

mRNA vaccine quality analysis using RNA sequencing

2023

Journal Article

Erratum: The splicing effect of variants at branchpoint elements in cancer genes (Genetics in Medicine (2022) 24(2) (398–409), (S109836002105348X), (10.1016/j.gim.2021.09.020))

Canson, Daffodil M., Dumenil, Troy, Parsons, Michael T., O'Mara, Tracy A., Davidson, Aimee L., Okano, Satomi, Signal, Bethany, Mercer, Tim R., Glubb, Dylan M. and Spurdle, Amanda B. (2023). Erratum: The splicing effect of variants at branchpoint elements in cancer genes (Genetics in Medicine (2022) 24(2) (398–409), (S109836002105348X), (10.1016/j.gim.2021.09.020)). Genetics in Medicine, 25 (1), 166-166. doi: 10.1016/j.gim.2022.11.015

Erratum: The splicing effect of variants at branchpoint elements in cancer genes (Genetics in Medicine (2022) 24(2) (398–409), (S109836002105348X), (10.1016/j.gim.2021.09.020))

2023

Journal Article

Long non-coding RNAs: definitions, functions, challenges and recommendations

Mattick, John S., Amaral, Paulo P., Carninci, Piero, Carpenter, Susan, Chang, Howard Y., Chen, Ling-Ling, Chen, Runsheng, Dean, Caroline, Dinger, Marcel E., Fitzgerald, Katherine A., Gingeras, Thomas R., Guttman, Mitchell, Hirose, Tetsuro, Huarte, Maite, Johnson, Rory, Kanduri, Chandrasekhar, Kapranov, Philipp, Lawrence, Jeanne B., Lee, Jeannie T., Mendell, Joshua T., Mercer, Timothy R., Moore, Kathryn J., Nakagawa, Shinichi, Rinn, John L., Spector, David L., Ulitsky, Igor, Wan, Yue, Wilusz, Jeremy E. and Wu, Mian (2023). Long non-coding RNAs: definitions, functions, challenges and recommendations. Nature Reviews Molecular Cell Biology, 24 (6), 430-447. doi: 10.1038/s41580-022-00566-8

Long non-coding RNAs: definitions, functions, challenges and recommendations

2022

Journal Article

Bioengineered textiles with peptide binders that capture SARS-CoV-2 viral particles

Navone, Laura, Moffitt, Kaylee, Johnston, Wayne A., Mercer, Tim, Cooper, Crystal, Spann, Kirsten and Speight, Robert E. (2022). Bioengineered textiles with peptide binders that capture SARS-CoV-2 viral particles. Communications Materials, 3 (1) 54, 1-9. doi: 10.1038/s43246-022-00278-8

Bioengineered textiles with peptide binders that capture SARS-CoV-2 viral particles

2022

Journal Article

The Coronavirus Standards Working Group’s roadmap for improved population testing

Mercer, Tim, Almond, Neil, Crone, Michael A., Chain, Patrick S. G., Deshpande, Alina, Eveleigh, Deepa, Freemont, Paul, Fuchs, Sebastien, Garlick, Russell, Huggett, Jim, Kammel, Martin, Li, Po-E, Milavec, Mojca, Marlowe, Elizabeth M., O’Sullivan, Denise M., Page, Mark, Pestano, Gary A., Suliman, Sara, Simen, Birgitte, Sninsky, John J., Sopchak, Lynne, Tato, Cristina M., Vallone, Peter M., Vandesompele, Jo, White, Thomas J., Zeichhardt, Heinz and Salit, Marc (2022). The Coronavirus Standards Working Group’s roadmap for improved population testing. Nature Biotechnology, 40 (11), 1563-1568. doi: 10.1038/s41587-022-01538-1

The Coronavirus Standards Working Group’s roadmap for improved population testing

2022

Journal Article

Library adaptors with integrated reference controls improve the accuracy and reliability of nanopore sequencing

Gunter, Helen M., Youlten, Scott E., Madala, Bindu Swapna, Reis, Andre L. M., Stevanovski, Igor, Wong, Ted, Kummerfield, Sarah K., Deveson, Ira W., Santini, Nadia S., Marcellin, Esteban and Mercer, Tim R. (2022). Library adaptors with integrated reference controls improve the accuracy and reliability of nanopore sequencing. Nature Communications, 13 (1) 6437, 1-11. doi: 10.1038/s41467-022-34028-8

Library adaptors with integrated reference controls improve the accuracy and reliability of nanopore sequencing

Funding

Current funding

  • 2026 - 2031
    IMPACT: Immunocellular Manufacturing Platform for Advanced Cell Therapies
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2025 - 2028
    Improving Quality Control of mRNA Manufacture with Nanopore Sequencing
    ARC Linkage Projects
    Open grant
  • 2024 - 2029
    Building mRNA Cancer Vaccines for Australia.
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2024 - 2029
    Australian Centre for RNA Therapeutics in Cancer (CRT Collaborative Cancer Research Grant - 2023 administered by University of Western Australia)
    University of Western Australia
    Open grant
  • 2023 - 2028
    Translational ecosystem for clinical development of mRNA modalities (MRFF mCTEI externally led by Southern RNA)
    Southern RNA PTY LTD
    Open grant
  • 2023 - 2028
    Base - NCRIS 2022 (administered by the Therapeutic Innovation Australia (TIA))
    Therapeutic Innovation Australia Limited
    Open grant
  • 2023 - 2028
    Building the next mRNA vaccines and therapies
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2023 - 2027
    Building RNA therapies to re-program gene expression.
    NHMRC Investigator Grants
    Open grant

Past funding

  • 2024
    Conjugation of targeting protein moieties to non-viral vectors such as lipid nanoparticles (LNPs) (University College London administered UKRI BBSRC grant)
    University College London
    Open grant
  • 2023 - 2024
    Optimisation of mRNA production and purification using the AMBR15 and AMBRCF
    Innovation Connections
    Open grant
  • 2022 - 2024
    Building Synthetic DNA Controls for Oxford Nanopore Sequencing
    NHMRC Development Grant
    Open grant
  • 2011 - 2012
    Receptor-specific targeting of extracellular RNA to recipient cells
    UQ Early Career Researcher
    Open grant

Supervision

Availability

Professor Timothy Mercer is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Professor Timothy Mercer's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au